A citation-based method for searching scientific literature

David Esopi, Mindy Kim Graham, Jacqueline A Brosnan-Cashman, Jennifer Meyers, Ajay Vaghasia, Anuj Gupta, Balasubramanian Kumar, Michael C Haffner, Christopher M Heaphy, Angelo M De Marzo, Alan K Meeker, William G Nelson, Sarah J Wheelan, Srinivasan Yegnasubramanian. Cell Oncol (Dordr) 2020
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
Donghyun D Lee, Ricardo Leão, Martin Komosa, Marco Gallo, Cindy H Zhang, Tatiana Lipman, Marc Remke, Abolfazl Heidari, Nuno Miguel Nunes, Joana D Apolónio,[...]. J Clin Invest 2019
10
100

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
201
100

Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells.
A Satyanarayana, S U Wiemann, J Buer, J Lauber, K E J Dittmar, T Wüstefeld, M A Blasco, M P Manns, K L Rudolph. EMBO J 2003
121
50

Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
Benedetta Donati, Alessandro Pietrelli, Piero Pingitore, Paola Dongiovanni, Andrea Caddeo, Lucy Walker, Guido Baselli, Serena Pelusi, Chiara Rosso, Ester Vanni,[...]. Cancer Med 2017
23
50

Whole chromosome loss is promoted by telomere dysfunction in primary cells.
Judit Pampalona, David Soler, Anna Genescà, Laura Tusell. Genes Chromosomes Cancer 2010
58
50



Telomere shortening is associated with cell division in vitro and in vivo.
R C Allsopp, E Chang, M Kashefi-Aazam, E I Rogaev, M A Piatyszek, J W Shay, C B Harley. Exp Cell Res 1995
393
50

The role of telomeres and telomerase in cirrhosis and liver cancer.
Jean-Charles Nault, Massih Ningarhari, Sandra Rebouissou, Jessica Zucman-Rossi. Nat Rev Gastroenterol Hepatol 2019
53
50

Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach.
Keun Soo Ahn, Daniel O'Brien, Yu Na Kang, Taofic Mounajjed, Yong Hoon Kim, Tae-Seok Kim, Jean-Pierre A Kocher, Loretta K Allotey, Mitesh J Borad, Lewis R Roberts,[...]. Hepatol Int 2019
7
50

Identification of genes involved in the regulation of TERT in hepatocellular carcinoma.
Masataka Amisaki, Hiroyuki Tsuchiya, Tomohiko Sakabe, Yoshiyuki Fujiwara, Goshi Shiota. Cancer Sci 2019
11
50

Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma.
Ruben R Plentz, Brigitte Schlegelberger, Peer Flemming, Michael Gebel, Hans Kreipe, Michael P Manns, K Lenhard Rudolph, Ludwig Wilkens. Hepatology 2005
45
50

hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer.
Richard Palmqvist, Anju Zhang, Dawei Xu, Irina Golovleva, Karl-Fredrik Norrback, Astrid Gruber, Ake Oberg, Roger Stenling, Göran Roos. Int J Cancer 2005
12
50

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
266
50

Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
Igor Girault, Sengül Tozlu, Rosette Lidereau, Ivan Bièche. Clin Cancer Res 2003
265
50

Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.
Paraskevi A Farazi, Jonathan Glickman, Shan Jiang, Alice Yu, Karl Lenhard Rudolph, Ronald A DePinho. Cancer Res 2003
104
50

Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
Patrick F Fogarty, Hiroki Yamaguchi, Adrian Wiestner, Gabriela M Baerlocher, Elaine Sloand, Weihua S Zeng, Elizabeth J Read, Peter M Lansdorp, Neal S Young. Lancet 2003
188
50

Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.
Camilla Pilati, Eric Letouzé, Jean-Charles Nault, Sandrine Imbeaud, Anaïs Boulai, Julien Calderaro, Karine Poussin, Andrea Franconi, Gabrielle Couchy, Guillaume Morcrette,[...]. Cancer Cell 2014
154
50

RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Tianze Liu, Wenbin Li, Wenjing Lu, Miao Chen, Meihua Luo, Changlin Zhang, Yixin Li, Ge Qin, Dingbo Shi, Binyi Xiao,[...]. Theranostics 2017
18
50

Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
N Miura, I Horikawa, A Nishimoto, H Ohmura, H Ito, S Hirohashi, J W Shay, M Oshimura. Cancer Genet Cytogenet 1997
136
50

Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
H Tahara, T Nakanishi, M Kitamoto, R Nakashio, J W Shay, E Tahara, G Kajiyama, T Ide. Cancer Res 1995
339
50

Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
André Lechel, Henne Holstege, Yvonne Begus, Andrea Schienke, Kenji Kamino, Ulrich Lehmann, Stefan Kubicka, Peter Schirmacher, Jos Jonkers, K Lenhard Rudolph. Gastroenterology 2007
46
50

The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma.
Xiaotian Yuan, Guanghui Cheng, Jingya Yu, Shunzhen Zheng, Chao Sun, Qing Sun, Kailin Li, Zhaomin Lin, Tiantian Liu, Ping Li,[...]. Oncotarget 2017
19
50

Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma.
Agrin Moeini, Daniela Sia, Nabeel Bardeesy, Vincenzo Mazzaferro, Josep M Llovet. Clin Cancer Res 2016
106
50

Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma.
Ruben R Plentz, Martin Caselitz, Joerg S Bleck, Michael Gebel, Peer Flemming, Stefan Kubicka, Michael P Manns, K Lenhard Rudolph. Hepatology 2004
91
50

hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
Xing Fan, Yunyue Wang, John Kratz, Dan J Brat, Yves Robitaille, Albert Moghrabi, Elizabeth J Perlman, Chi V Dang, Peter C Burger, Charles G Eberhart. Am J Pathol 2003
57
50

Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.
Stefanie U Wiemann, Ande Satyanarayana, Martina Tsahuridu, Hans L Tillmann, Lars Zender, Juergen Klempnauer, Peer Flemming, Sonia Franco, Maria A Blasco, Michael P Manns,[...]. FASEB J 2002
327
50

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Kornelius Schulze, Sandrine Imbeaud, Eric Letouzé, Ludmil B Alexandrov, Julien Calderaro, Sandra Rebouissou, Gabrielle Couchy, Clément Meiller, Jayendra Shinde, Frederic Soysouvanh,[...]. Nat Genet 2015
761
50

Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma.
Seung Eun Lee, Seong-Hwan Chang, Wook Youn Kim, So Dug Lim, Wan Seop Kim, Tea Sook Hwang, Hye Seung Han. Oncotarget 2016
19
50

Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers.
Vassiliki Kotoula, Prodromos Hytiroglou, Athina Pyrpasopoulou, Romil Saxena, Swan N Thung, Constantine S Papadimitriou. Liver 2002
42
50

Telomerase activity in precancerous hepatic nodules.
P Hytiroglou, V Kotoula, S N Thung, M Tsokos, M I Fiel, C S Papadimitriou. Cancer 1998
46
50

The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.
T Vulliamy, A Marrone, F Goldman, A Dearlove, M Bessler, P J Mason, I Dokal. Nature 2001
681
50

Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features.
Xiangchun Li, Weiqi Xu, Wei Kang, Sunny H Wong, Mengyao Wang, Yong Zhou, Xiaodong Fang, Xiuqing Zhang, Huanming Yang, Chi H Wong,[...]. Theranostics 2018
35
50

Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence.
Motoko Sasaki, Hiroko Ikeda, Junpei Yamaguchi, Satoko Nakada, Yasuni Nakanuma. Hepatology 2008
76
50

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
209
50

Phenotypic and molecular changes in nodule-in-nodule hepatocellular carcinoma with pathogenetic implications.
Noemi Rudini, Chiara Novello, Annarita Destro, Elena Riboldi, Matteo Donadon, Luca Viganò, Emanuela Morenghi, Massimo Roncalli, Luca Di Tommaso. Histopathology 2018
8
50

Hypervariable ultra-long telomeres in mice.
D Kipling, H J Cooke. Nature 1990
479
50

Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions.
Anitha Suram, Jessica Kaplunov, Priyanka L Patel, Haihe Ruan, Aurora Cerutti, Virginia Boccardi, Marzia Fumagalli, Raffaella Di Micco, Neena Mirani, Resham Lal Gurung,[...]. EMBO J 2012
140
50

Pathogenesis of hepatocellular carcinoma according to aetiology.
Jean-Charles Nault. Best Pract Res Clin Gastroenterol 2014
37
50

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Masatoshi Kudo, Richard S Finn, Shukui Qin, Kwang-Hyub Han, Kenji Ikeda, Fabio Piscaglia, Ari Baron, Joong-Won Park, Guohong Han, Jacek Jassem,[...]. Lancet 2018
50

DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene.
T R Devereux, I Horikawa, C H Anna, L A Annab, C A Afshari, J C Barrett. Cancer Res 1999
179
50

Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations.
Masashi Fujita, Rui Yamaguchi, Takanori Hasegawa, Shu Shimada, Koji Arihiro, Shuto Hayashi, Kazuhiro Maejima, Kaoru Nakano, Akihiro Fujimoto, Atsushi Ono,[...]. EBioMedicine 2020
14
50

The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferation.
Hüseyin Sirma, Mukesh Kumar, Jitendra K Meena, Britta Witt, Julia M Weise, Andre Lechel, Satyanarayana Ande, Vadim Sakk, Christiane Guguen-Guillouzo, Lars Zender,[...]. Gastroenterology 2011
24
50

Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Jingya Yu, Xiaotian Yuan, Louise Sjöholm, Tiantian Liu, Feng Kong, Tomas J Ekström, Magnus Björkholm, Dawei Xu. Cancer Lett 2018
23
50

Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
Jessica Zucman-Rossi, Augusto Villanueva, Jean-Charles Nault, Josep M Llovet. Gastroenterology 2015
539
50

Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma.
Hye Won Lee, Tae In Park, Se Young Jang, Soo Young Park, Won-Jin Park, Soo-Jung Jung, Jae-Ho Lee. Medicine (Baltimore) 2017
12
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma.
Wan Huang, Weiping Zhou, Can Li, Yuan Yang, Yu-Kui Shang, Changsheng Chen, Jing Zhang, Rui Yao, Pei Wang, Wen Wen,[...]. Oncotarget 2017
4
50

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma.
Ling-Hao Zhao, Xiao Liu, He-Xin Yan, Wei-Yang Li, Xi Zeng, Yuan Yang, Jie Zhao, Shi-Ping Liu, Xue-Han Zhuang, Chuan Lin,[...]. Nat Commun 2016
122
50

Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage.
Stefanie U Wiemann, Ande Satyanarayana, Jan Buer, Kenji Kamino, Michael P Manns, Karl Lenhard Rudolph. Oncogene 2005
16
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.